First Horizon Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-445
| Closed | -$12.7K | – | 2381 |
|
|
2024
Q2 | $12.7K | Buy |
445
+12
| +3% | +$343 | ﹤0.01% | 1435 |
|
|
2024
Q1 | $12.7K | Hold |
433
| – | – | ﹤0.01% | 1505 |
|
|
2023
Q4 | $14.6K | Hold |
433
| – | – | ﹤0.01% | 1452 |
|
|
2023
Q3 | $13.3K | Hold |
433
| – | – | ﹤0.01% | 1405 |
|
|
2023
Q2 | $17.4K | Hold |
433
| – | – | ﹤0.01% | 1323 |
|
|
2023
Q1 | $17.7K | Hold |
433
| – | – | ﹤0.01% | 1306 |
|
|
2022
Q4 | $16.7K | Sell |
433
-3
| -0.7% | -$116 | ﹤0.01% | 1318 |
|
|
2022
Q3 | $23K | Hold |
436
| – | – | ﹤0.01% | 1178 |
|
|
2022
Q2 | $25K | Buy |
436
+433
| +14,433% | +$24.8K | ﹤0.01% | 1204 |
|
|
2022
Q1 | $0 | Sell |
3
-433
| -99% | – | ﹤0.01% | 2139 |
|
|
2021
Q4 | $26K | Sell |
436
-127
| -23% | -$7.57K | ﹤0.01% | 1184 |
|
|
2021
Q3 | $31K | Buy |
563
+286
| +103% | +$15.7K | ﹤0.01% | 1108 |
|
|
2021
Q2 | $16K | Hold |
277
| – | – | ﹤0.01% | 1193 |
|
|
2021
Q1 | $19K | Sell |
277
-91
| -25% | -$6.24K | ﹤0.01% | 1099 |
|
|
2020
Q4 | $22K | Buy |
368
+172
| +88% | +$10.3K | ﹤0.01% | 867 |
|
|
2020
Q3 | $11K | Buy |
+196
| New | +$11K | ﹤0.01% | 983 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1471 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1566 |
|